Informa
2025年12月14-17日
米国、カリフォルニア州サンディエゴ、Marriott Marquis対面式ライブイベント: 2025年12月14-17日

科学プログラムパートナー

抗体学会と共同で作成した会議アジェンダ

Antibody Engineering & Therapeutics 2025
-抗体エンジニアリング・治療学会:2025-
開催日:2025年12月14-17日
開催地:米国、カリフォルニア州サンディエゴ、Marriott Marquis
※会議開催後のオンデマンド視聴のお申し込みも受け付けております。詳細はお問い合わせください。

Accelerating Tomorrow's Antibody Therapeutics Today

The Summit of Antibody Science and Your Path to Commercial Success

Antibodies • Proteins • Bispecifics • Multispecifics • ADCs

Choose your language
Traditional Chinese
Simplified Chinese
Korean
English

What’s Waiting for You in Sunny San Diego

135+

World-Class Speaker Presentations

900+

Antibody Scientists & Executives

75+

Leading Industry Exhibitors

125+

Scientific Posters Highlighting Breakthrough Research

Where Antibody Breakthroughs Begin

Get an inside look at this year’s agenda - packed with world-class speakers and forward-thinking research across antibody engineering and therapeutic development.

Novel Bispecific and Multi-specific Antibodies

  • Explore advanced multispecific formats to overcome therapeutic limitations

  • Case studies on bispecific ADCs and conditional activation platforms

  • Engineering strategies for glycan targeting, avidity, and stability

Antibody Therapeutics in Emerging Disease Areas: Non-Oncology

  • Novel antibodies for fibrosis, cardiovascular disease, and CNS delivery

  • Innovative biologics targeting innate and adaptive immune pathways

  • Translating discoveries into therapies for complex non-oncology indications

Innovative Engineering for Cell Engagers

  • AI-driven design and next-gen T-cell engager platforms

  • Strategies to improve potency, selectivity, and safety in immunotherapy

  • Novel conditional engagers and dual-binding antibodies in cancer therapy

Antibody and Protein Therapeutics in Inflammation, Autoimmunity and Allergy

  • Breakthroughs in cell depletion strategies for autoimmune diseases

  • Next-gen cytokine blockers and trispecific antibodies for inflammation

  • Novel approaches to allergy treatment, from IgE cleavage to immune modulation

Emerging In Vitro Approaches to Antibody Discovery

  • Cutting-edge display technologies and high-throughput screening platforms

  • Computational and AI-driven antibody engineering for speed and precision

  • Case studies on de novo antibody design and rapid evolution systems

Engineering Innovative Formats and Scaffolds

  • Nanobody and knottin engineering for novel therapeutic applications

  • Advances in GPCR-targeting formats and allosteric modulators

  • Overcoming immunogenicity challenges with new scaffold architectures

Advanced In Vivo Antibody Discovery

  • Leveraging animal models and immune organoids for breakthrough discovery

  • In vivo screening approaches for CNS delivery and biodistribution

  • Strategies to accelerate discovery of antibodies against infectious diseases

Antibody Drug Conjugates - Novel Payloads and Engineering

  • Dual-payload ADCs for enhanced efficacy and resistance management

  • Site-specific conjugation techniques for stability and safety

  • Novel non-cytotoxic payloads and improved therapeutic index strategies

Engineering Considerations for Candidate Selection and Developability

  • Early risk mitigation for immunogenicity and chemical liabilities

  • ML-driven workflows for predictive developability optimization

  • High-throughput strategies for complex biologics like ADCs and bispecifics

Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics

  • Investor perspectives on value creation and biotech funding trends

  • Lessons from successful preclinical-to-clinic transitions

  • Strategic insights for commercialization and portfolio optimization

Enhanced Efficacy Through Fc Engineering

  • Fc modifications to optimize effector function and immune activation

  • Site-specific conjugation and glycoengineering breakthroughs

  • Translating Fc innovations into next-gen therapeutics

Novel Extracellular Protein Degraders & Beyond

  • Cutting-edge eTPD platforms for transmembrane and extracellular targets

  • Novel bispecific degrader technologies and conjugate strategies

  • Expanding the druggable proteome beyond traditional antibody modalities

The Science. The Networking. The Moments.

Last year set the stage - 2025 will raise the bar. Watch the 2024 highlights, then join us this December in San Diego for the world’s leading antibody engineering event.

Ways to Attend

Join the Antibody Event of the Year in San Diego!

Get ready for 4 days of breakthrough science, powerful networking, and cutting-edge innovation at Antibody Engineering & Therapeutics US. This is your chance to:

✓ Access exclusive insights from 135+ world-renowned speakers sharing never-before-seen data and real-world case studies.
✓ Connect with 75+ leading solution providers driving the next wave of antibody engineering and therapeutic development.
✓ Explore the entire antibody landscape - from discovery and design to clinical development and commercialization.

Whether you’re passionate about bispecifics, ADCs, AI-driven discovery, or next-gen formats, this is where the future of antibody therapeutics takes shape.

Join us in sunny San Diego or tune in virtually from anywhere!

Showcase Your Research - Add a Poster Presentation

When you register for an in-person or digital Main Conference Pass (or Main Conference + Workshop Pass), you’ll have the exclusive opportunity to elevate your experience by adding a poster presentation for just $199.

This is your chance to:
✓ Showcase your research to leading scientists and industry innovators
✓ Spark meaningful discussions and gain valuable feedback
✓ Expand your professional visibility within the global antibody community

Don’t miss this opportunity to amplify your presence and make an impact!

Partner with the World’s Leading Antibody Event

Seize the opportunity to connect with key decision-makers and industry pioneers shaping the future of antibody therapeutics. As a sponsor of Antibody Engineering & Therapeutics US, your brand will be front and center at the industry’s most influential event, giving you:

✓ Unparalleled access to top biopharma leaders and innovators
✓ Opportunities to showcase your solutions to an engaged audience actively seeking new technologies and partnerships
✓ Direct connections that accelerate your business growth in the antibody and protein therapeutics market

Don’t miss your chance to position your brand at the forefront of antibody innovation.

Fridtjof Lund-Johansen

Senior Scientist

Oslo University Hospital, Rikshospitalet

The on-line format of this meeting was in fact even better than the physical meeting. I loved having the opportunity to revisit presentations and roll back the slides. I could do everything in my own pace without having to rush between sessions.

An ideal meeting for anyone interested in antibodies and antibody engineering! Great content and good opportunities to meet with highly innovative people both from academia and industry.

抗体学会について

抗体学会は、抗体関連の研究開発に従事する個人・組織を支援する国際的な非営利業界団体です。バイオ医薬品業界が開発する標的医薬に関するデータを研究・分析し、その成果と解説を学会のWebサイト、プレゼンテーション、出版物を通じて発表しています。学会は、教育的なWebセミナーやシンポジウムを開催するほか、抗体・T細胞受容体の次世代シーケンシングの生成、利用、共有、標準化に焦点を当てたAIRR(適応免疫受容体レパートリー)コミュニティの拠点としての役割も担っています。また、抗体コミュニティに対する重要な問題について国際機関とも連携しています。

学会メンバーは、Antibody Engineering & Therapeutics 会議において科学顧問を務めています。会議の科学プログラムは、学会の会議委員会によって考案されています。

Antibody Engineering & Therapeutics USで、質の高い意思決定者に関わる

質の高いリード獲得、ソートリーダーの紹介、ブランドの強化など、何でもご相談ください。ビジネス目標の達成に役立つ、カスタムなスポンサーシップの機会をご提案いたします。

詳細については、株式会社グローバルインフォメーションまでお問い合わせください。